# Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors

> **NCT00221195** · PHASE2,PHASE3 · COMPLETED · sponsor: **Tulane University School of Medicine** · enrollment: 34 (actual)

## Conditions studied

- Hemophilia A With Inhibitors

## Interventions

- **DRUG:** activated prothrombin complex concentrate (FEIBA)

## Key facts

- **NCT ID:** NCT00221195
- **Lead sponsor:** Tulane University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-07
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221195, "Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00221195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*